Company: NDRA
Filing Date: 2025-07-09
Form Type: 8-K
Source: 0001654954-25-007893
Chunk: 1

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-07-09
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                   
         99.1      Excerpt from Prospectus, dated July 9, 2025.                                  
 ─────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the inline XBRL document).  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  ENDRA Life Sciences Inc.                               
  July 9, 2025                                           
  By:                           /s/ Richard Jacroux      
  Name:                         Richard Jacroux          
  Title:                        Chief Financial Officer  

   3